97. Steroid Pretreatment of Organ Donors to Prevent Postischemic Renal Allograft Failure. A Randomized, Controlled Trial. Ann Int Med 2010; 153:222-230. (IF 19.6)

Kainz A, Wilflingseder J, Mitterbauer C, Haller M, Burghuber C, Perco P, Langer RM, Heinze G, Oberbauer R.

95. Association of ESA hypo-responsiveness and haemoglobin variablility with mortality in haemodialysis patients. Nephrol Dial Transplant 2010; 25:3701-3706. (IF 4.8)

Kainz A, Mayer B, Kramar R, Oberbauer R.

94. Linking transcriptomics and proteomics data on the level of protein interaction networks. Electrophoresis 2010; 31:1780-1789. (IF 3)

Perco P, Mühlberger I, Mayer G, Oberbauer R, Lukas A, Mayer B.

93. Impaired metabolism in donor kidney grafts after steroid pretreatment. Transpl Int 2010; 23:796-804. (IF 2.7)

Wilflingseder J, Kainz A, Mühlberger I, Perco P, Langer R, Kristo I, Mayer B, Oberbauer R.

92. Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int 2010; 23:777-785. (IF 2.7)

Haidinger M, Hecking M, Weichhart T, Poglitsch M, Enkner W, Vonbank K, Prayer D, Geusau A, Oberbauer R, Zlabinger GJ, Soleiman A, Hörl WH., Säemann MD.

91. Glucose control is associated with patient survival in diabetic patients after renal transplantation. Transplantation 2010; 89:612-619. (IF 5.3)

Wiesbauer F, Heinze G, Regele H, Hörl WH, Schernthaner GH, Schwarz C, Kainz A, Kramar R, Oberbauer R.

89. Non-persistent effect of short-term bisphosphonate treatment in preventing fractures after liver transplantation. Transpl Int 2010; 23:118-120. (IF 2.7)

Bodingbauer M, Pakrah B, Kristo I, Marschalek J, Burghuber C, Györi G, Kainz A, Rasoul-Rockenschaub S, Klaushofer K, Muehlbacher F, Oberbauer R.

87. Antithymocyte globulin use for treatment of biopsy confirmed acute rejection is associated with prolonged renal allograft survival. Transpl Int 2010; 23:64-70. (IF 2.7)

Kainz A, Korbely R, Soleiman A, Mayer B, Oberbauer R.

SCIENTIFIC COLLABORATIONS